View Clinical Trial (Medical Research Study)


A Laboratory Model for Heroin Abuse Medications - 8 - NCT00000273-10032(Clinical Trial 111020)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  New York
State:  
NY
Zip Code: 10032
Conditions: Heroin Dependence - Opioid-Related Disorders - Substance-Related Disorders
Purpose: The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."
Study summary:
Criteria: Please contact site for information.
Study is available at: Columbia University
New York, NY 10032
United States

Primary Contact:
Sandra D Comer, Ph.D.
Email: sdc10@columbia.edu
Phone: 212-543-5981

Secondary Contact:
Sandra D Comer, Ph.D.
Email: sdc10@columbia.edu
Phone: 212-543-5981
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 21, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.